ENLV ▲ +4.4% - Enlivex Ltd. $ENLV - Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis 28-OCT-2026 08:00 AM ET